Skip to main content
. Author manuscript; available in PMC: 2009 Oct 30.
Published in final edited form as: J Neurosurg. 2008 Oct;109(4):699–707. doi: 10.3171/JNS/2008/109/10/0699

TABLE 2. Summary of demographic data*.

Cyclosporine Groups

Variable I II III IV Placebo Group
no. of patients 8 8 8 8 8
 M 7 7 7 3 8
 F 1 1 1 5 0
GCS score (± SD) 6.5 ± 0.93 5.5 ± 1.5 5.9 ± 0.99 6.3 ± 1.4 6.0 ± 0.76
 4 1 1 1 1 1
 5–7 7 6 7 4 7
 8 0 1 0 3 0
age (± SD) 29 ± 6.0 32 ± 14.6 23 ± 8.2 34 ± 14.8 6 ± 6.6
Marshall CT classification
 I 0 0 0 0 0
 II 1 2 1 0 1
 II + SAH 1 3 3 4 2
 III 0 0 0 1 0
 III + SAH 2 0 1 0 0
 V 2 2 0 1 4
 IV + SAH 1 0 0 1 0
 SAH only 0 1 1 0 0
 evacuated mass lesion 1 0 1 0 0
 nonevcuated mass lesion + SAH 0 0 1 1 1
*

Values represent numbers of patients unless otherwise indicated. Abbreviations: SAH = subarachnoid hemorrhage; SD = standard deviation.

As defined in Marshall et al., 1991.